HIV Rapid Test | STD TESTING SINGAPORE™
HIV Rapid Test | STD TESTING SINGAPORE™ @stdtestingsingapore_com: HIV (human immunodeficiency virus) rapid test, Singapore. Private & confidential service.
Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
| SHIM CLINIC|
STD TESTING SINGAPORE™
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: HIV Rapid Test | STD TESTING SINGAPORE™
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
Table of Contents HIV rapid test (20 minutes to results) Two types are available:
Note: If the clinic attendance is only for the HIV rapid test, then consultation fees are not added.
References HIV is the abbreviation for the human immunodeficiency virus, which causes the acquired immunodeficiency syndrome
HIV symptoms which may present in acute HIV infection: These are nonspecific symptoms and can present with other infections; consequently, they are unreliable indicators of HIV infection.
Remember, there is no HIV cure.
HIV window period is the time from HIV infection until a HIV Test can detect any change. Within the HIV window period, the HIV Test would be negative. During this period, the HIV viral load is extremely high, thus making the person highly infectious.
References HIV Test
- 4 weeks after exposure, a negative 4th generation HIV ELISA Test "is very reassuring / highly likely to exclude HIV infection."
- 12 weeks after exposure, a negative 3rd generation HIV ELISA Test "would definitively exclude HIV infection."
HIV ELISA (Enzyme-linked immunosorbent assay) test generations:
References HIV PCR (polymerase chain reaction) NAT (nucleic acid test) HIV Risk (2009 figures)
- 1st generation: HIV-1 IgG antibody
- 2nd generation: HIV-1 & HIV-2 IgG antibodies
- 3rd generation: HIV-1 & HIV-2 IgG & IgM antibodies
- 4th generation: HIV-1 & HIV-2 IgG & IgM antibodies and HIV p24 antigen
Estimated HIV transmission risk per exposure for specific activities and events
|Activity ||Risk-per-exposure |
|Vaginal sex, female-to-male, studies in high-income countries ||0.04% (1:2380) |
|Vaginal sex, male-to-female, studies in high-income countries ||0.08% (1:1234) |
|Vaginal sex, female-to-male, studies in low-income countries ||0.38% (1:263) |
|Vaginal sex, male-to-female, studies in low-income countries ||0.30% (1:333) |
|Vaginal sex, source partner is asymptomatic ||0.07% (1:1428) |
|Vaginal sex, source partner has late-stage disease ||0.55% (1:180) |
|Receptive anal sex amongst gay men, partner unknown status ||0.27% (1:370) |
|Receptive anal sex amongst gay men, partner HIV positive ||0.82% (1:123) |
|Receptive anal sex with condom, gay men, partner unknown status ||0.18% (1:555) |
|Insertive anal sex, gay men, partner unknown status ||0.06% (1:1666) |
|Insertive anal sex with condom, gay men, partner unknown status ||0.04% (1:2500) |
|Receptive fellatio ||Estimates range from 0.00% to 0.04% (1:2500) |
|Mother-to-child, mother takes at least two weeks antiretroviral therapy ||0.8% (1:125) |
|Mother-to-child, mother takes combination therapy, viral load below 50 ||0.1% (1:1000) |
|Injecting drug use ||Estimates range from 0.63% (1:158) to 2.4% (1:41) |
|Needlestick injury, no other risk factors ||0.13% (1:769) |
|Blood transfusion with contaminated blood ||92.5% (9:10) |
Sources: vaginal sex;1 anal sex;2 fellatio;3 2 mother-to-child;4 other activities.5
- Boily MC et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9(2): 118-129, 2009
- Vittinghoff E et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. American Journal of Epidemiology 150: 306-311, 1999
- Del Romero J et al. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS 16(9): 1296-1297, 2002
- Townsend C et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 22: 973-981, 2008
- Baggaley RF et al. Risk of HIV-1 transmission for parenteral exposure and blood transfusion. AIDS 20: 805-812, 2006
- HIV & AIDS Information :: How transmission occurs - Estimated risk per exposure
HIV Risk (2005 figures)
Estimated per-act risk for acquisition of HIV, by exposure route*
*Estimates of risk for transmission from sexual exposures assume no condom use.
|Exposure route||Risk per 10,000|
to an infected source
|Needle-sharing injection-drug use||67||0.67|
|Receptive anal intercourse||50||0.5|
|Percutaneous needle stick||30||0.3|
|Receptive penile-vaginal intercourse||10||0.1|
|Insertive anal intercourse||6.5||0.065|
|Insertive penile-vaginal intercourse||5||0.05|
|Receptive oral intercourse†||1||0.01|
|Insertive oral intercourse†||0.5||0.005|
†Source refers to oral intercourse performed on a man.
HIV risk (2002 figures)
HIV Risk Statistics (chances of getting HIV)
|HIV Risk Factors ||HIV Transmission Probability |
|Needle stick injury3 ||1/300 |
|Receptive anal intercourse4 ||1/100 |
|Receptive vaginal intercourse5 ||1/1000 |
|Insertive vaginal intercourse4 ||1/2000 |
|Insertive anal intercourse4 ||1/2500 |
|Receptive fellatio with ejaculation4 ||1/2500 |
|Sharing needles6 ||1/150 |
HIV prevention / HIV PEP (post-exposure prophylaxis) treatment can prevent you from getting an HIV infection, and turning HIV positive.
- Cardo DM, Culver DH, Ciesielski CA, et al. A Case-Control Study of HIV Seroconversion in Health Care Workers after Percutaneous Exposure. N Engl J Med. 1997;337:1485-1490.
- Katz MH, Gerberding JL. Management of occupational and nonoccupational postexposure HIV prophylaxis. Current Inf Dis Reports. 2002;4:543-549.
- Gerberding JL. Prophylaxis for Occupational Exposure to HIV. Ann Intern Med. 1996;6:497-501
- Vitinghoff E, Douglas J, Judon F, et al. Per-Contact Risk of Human Immunodificiency Virus Transmision between Male Sexual Partners. Am J Epidemiol. 1999;150:306-311.
- Peterman TA, Stoneburner RL, Allen JR, et al. Risk of Human Immunodeficiency Virus Transmission From Heterosexual Adults With Transfusion-Associated Infections. JAMA. 1988;259:55-58. [Erratum. JAMA. 1989;262:502]
- Kaplan EH, Heimer R. A Model-Based Estimate of HIV Infectivity via Needle Sharing. J Acquir Immune Defic Syndr. 1992;5:1116-1118.
Individuals are eligible for HIV PEP Treatment if all the following criteria are met:
Prompt antiviral therapy may reduce the risk of HIV transmission by as much as 80%.
- less than 72 hours has elapsed since exposure;
- the exposed individual is not known to be HIV infected;
- the person who is the source of exposure is HIV infected or has unknown HIV status;
- mucous membrane or non-intact skin was exposed to a potentially infectious body fluid;
For optimal efficacy, antiretroviral therapy should be started as soon as possible, ideally within 1 hour of exposure. So that you can remain HIV negative.
The medications and dosages are the same as those used for lifelong treatment of HIV patients. However, for HIV PEP treatment, it is taken for only a month.
References Drugs commonly used in HIV PEP: References TORCH
(of HIV/STD/pregnancy), and what you can do before and after exposure.
HIV Testing and Awareness of Partner’s HIV Status Among Chinese Men Who Have Sex with Men in Main Partnerships
Tue, 30 Jun 2015 00:00:00 +0100 | AIDS and Behavior
Sex Differences in HIV Prevalence, Behavioral Risks and Prevention Needs Among Anglophone and Francophone Sub-Saharan African Migrants Living in Rabat, Morocco
Tue, 30 Jun 2015 00:00:00 +0100 | AIDS and Behavior
Depressive Symptoms, Substance Use and Partner Violence Victimization Associated with HIV Disclosure Among Men Who have Sex with Men
Tue, 30 Jun 2015 00:00:00 +0100 | AIDS and Behavior
Paid Support Workers for Adults with Intellectual Disabilities; Their Current Knowledge of Hearing Loss and Future Training Needs
Mon, 29 Jun 2015 23:55:12 +0100 | Journal of Applied Research in Intellectual Disabilities
ConclusionsCurrent training is not sufficient to provide the skills for detection and management of hearing problems. This group had clear ideas on methods of learning. Working in collaboration is necessary to achieve long‐term change to practice. (Source: Journal of Applied Research in Intellectual Disabilities)
ICYMI: The Perils Of A Bad Mug Shot And Why STD-Testing Condoms Might Not Be That Awesome
Mon, 29 Jun 2015 19:39:10 +0100 | Healthy Living - The Huffington Post
ICYMI Health features what we're reading this week. This week, first-person essays by individuals affected by stigmatized diseases and disorders caught our eye. We spent time with the account of a writer struggling with chronic kidney damage from the lithium she has used to manage her bipolar disorder for 20 years. We had our hearts broken reading about a sister who had to pick up the pieces after her talented sibling died of a drug overdose. And we tuned in when a handful of a celebrities described how it feels to have a panic attack -- a good reminder that anxiety can affect anyone, regardless of life circumstances. Read on and tell us in the comments: What did you read and love this week? 1. The New Normal: Navigating Life After Harris' Death -- The Huffington Post A heart-wrenching ...
The Quality Of Health Care You Receive Likely Depends On Your Skin Color
Mon, 29 Jun 2015 19:24:04 +0100 | Healthy Living - The Huffington Post
Unequal health care continues to be a serious problem for black Americans. More than a decade after the Institute of Medicine issued a landmark report showing that minority patients were less likely to receive the same quality health care as white patients, racial and ethnic disparities continue to plague the U.S. health care system. That report, which was published in 2002, indicated that even when both groups had similar insurance or the same ability to pay for care, black patients received inferior treatment to white patients. This still hold true, according to our investigation into dozens of studies about black health across multiple disciplines. More than any other single group, the black community is most likely to have negative health outcomes, including higher rates of breast and ...
Why Larry Kramer's Galvinizing Message About LGBT Activism Is The Same As It's Always Been
Mon, 29 Jun 2015 17:21:30 +0100 | Healthy Living - The Huffington Post
“I still have that anger and I would still like to galvanize everyone, but it doesn’t appear that we’re galvanize-able as a population,” AIDS activist, author and playwright Larry Kramer said, discussing why LGBT activism is so necessary at a time in which he fears complacency has set in. That anger is on full display in the new documentary about his life and work as an activist and writer, “Larry Kramer in Love and Anger,” which debuts on HBO tonight at 9 p.m. “[It’s] too bad,” he continued, in an interview with me on SiriusXM Progress, referring to the the vital work ahead for activists on AIDS and LGBT rights,“because we need activism more than ever now.” That message – “we need activism more than ever now” -- is actually the message Kramer, who turned 80 la...
Botswana: Government Appeals ARV Judgement
Mon, 29 Jun 2015 14:34:12 +0100 | AllAfrica News: HIV-Aids and STDs
[Botswana Daily News] Gaborone -Justice Ian Kirby of the Court of Appeal will tomorrow (June 30) preside over a case in which the Attorney General is appealing Justice Key Dingake's judgement on provision of ARVs to foreign inmates. (Source: AllAfrica News: HIV-Aids and STDs)
Uganda: Aids Fight Gets Shs 745 Billion Boost
Mon, 29 Jun 2015 12:29:53 +0100 | AllAfrica News: HIV-Aids and STDs
[Observer] Uganda last week got five grants worth $226m (Shs 745bn) from the Global Fund to fight Aids, Tuberculosis and Malaria (GFATM). (Source: AllAfrica News: HIV-Aids and STDs)
Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management.
Mon, 29 Jun 2015 11:42:04 +0100 | Journal of the International AIDS Society
CONCLUSIONS: Our high efficiency subtype-independent HIV-NFLG is a simple and promising approach to be used in large-scale molecular epidemiological studies. It will facilitate the understanding of the HIV-1 pandemic population dynamics and outline effective intervention strategies. Furthermore, it can potentially be applicable in clinical management of drug resistance by evaluating DRMs against all available antiretrovirals in a single assay.